share_log

Merck & Co | 4: Statement of changes in beneficial ownership of securities-Officer Litchfield Caroline

SEC announcement ·  Feb 15 16:10
Summary by Moomoo AI
On February 14, 2024, Caroline Litchfield, EVP & CFO of Merck & Co., Inc. [MRK], completed a sale of 38,291 shares of common stock at a price of $125.50 per share. The transaction resulted in a total market value of $4,805,520.50. Prior to this sale, Litchfield exercised options to acquire the same number of shares at $58.08 per share. Following these transactions, Litchfield's direct holdings in Merck & Co. amounted to 50,908.194 shares of common stock.
On February 14, 2024, Caroline Litchfield, EVP & CFO of Merck & Co., Inc. [MRK], completed a sale of 38,291 shares of common stock at a price of $125.50 per share. The transaction resulted in a total market value of $4,805,520.50. Prior to this sale, Litchfield exercised options to acquire the same number of shares at $58.08 per share. Following these transactions, Litchfield's direct holdings in Merck & Co. amounted to 50,908.194 shares of common stock.
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more